These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 25129277)
21. Natriuretic peptides in heart failure and acute coronary syndrome. Gaggin HK; Januzzi JL Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786 [TBL] [Abstract][Full Text] [Related]
22. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Loke I; Squire IB; Davies JE; Ng LL Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197 [TBL] [Abstract][Full Text] [Related]
23. Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide. Ibebuogu UN; Gladysheva IP; Houng AK; Reed GL Circ Heart Fail; 2011 Mar; 4(2):114-20. PubMed ID: 21216831 [TBL] [Abstract][Full Text] [Related]
24. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. Clerico A; Passino C; Franzini M; Emdin M Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871 [TBL] [Abstract][Full Text] [Related]
25. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels]. Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251 [TBL] [Abstract][Full Text] [Related]
26. Atrial Natriuretic Peptide - Old But New Therapeutic in Cardiovascular Diseases. Ichiki T; Burnett JC Circ J; 2017 Jun; 81(7):913-919. PubMed ID: 28552863 [TBL] [Abstract][Full Text] [Related]
27. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
28. Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. Pettersson A; Hedner J; Hedner T; Held P; Swedberg K; Towle AC Eur Heart J; 1986 Aug; 7(8):693-6. PubMed ID: 2945719 [TBL] [Abstract][Full Text] [Related]
29. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742 [TBL] [Abstract][Full Text] [Related]
30. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Cowie MR; Struthers AD; Wood DA; Coats AJ; Thompson SG; Poole-Wilson PA; Sutton GC Lancet; 1997 Nov; 350(9088):1349-53. PubMed ID: 9365448 [TBL] [Abstract][Full Text] [Related]
31. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975 [TBL] [Abstract][Full Text] [Related]
32. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort. Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215 [TBL] [Abstract][Full Text] [Related]
33. Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. Vassalle C; Andreassi MG; Prontera C; Fontana M; Zyw L; Passino C; Emdin M Clin Chem; 2007 Nov; 53(11):1886-90. PubMed ID: 17890443 [TBL] [Abstract][Full Text] [Related]
34. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996 [TBL] [Abstract][Full Text] [Related]
35. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides. Maisel AS; Duran JM; Wettersten N Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197 [TBL] [Abstract][Full Text] [Related]
39. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600 [TBL] [Abstract][Full Text] [Related]
40. Molecular forms of natriuretic peptides in heart failure and their implications. Xu-Cai YO; Wu Q Heart; 2010 Mar; 96(6):419-24. PubMed ID: 19451138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]